SIMPLEX TRADING, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is and the CUSIP is 90400D958. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$367
+115.9%
10,300
+178.4%
0.00%
Q2 2023$170
+32.8%
3,700
+15.6%
0.00%
Q1 2023$128
+156.0%
3,200
+190.9%
0.00%
Q4 2022$50
-100.0%
1,100
-86.2%
0.00%
Q3 2022$331,000
+1847.1%
8,000
+2566.7%
0.00%
Q2 2022$17,000
-89.8%
300
-87.0%
0.00%
Q1 2022$167,000
+187.9%
2,300
+228.6%
0.00%
Q4 2021$58,000
+427.3%
700
+69900.0%
0.00%
Q1 2021$11,000
+37.5%
10.0%0.00%
Q3 2020$8,000
-99.5%
1
-99.5%
0.00%
-100.0%
Q2 2020$1,666,000
+414.2%
213
+191.8%
0.00%
+200.0%
Q1 2020$324,000
-81.9%
73
-82.6%
0.00%
-75.0%
Q4 2019$1,789,000
+94.7%
419
+94.9%
0.00%
+33.3%
Q3 2019$919,000
+944.3%
215
+1435.7%
0.00%
Q2 2019$88,000
-9.3%
140.0%0.00%
Q1 2019$97,000
-63.4%
14
-77.0%
0.00%
-100.0%
Q4 2018$265,000
+3685.7%
61
+6000.0%
0.00%
Q3 2018$7,000
-86.8%
1
-85.7%
0.00%
Q2 2018$53,000
+1225.0%
7
-22.2%
0.00%
Q1 2018$4,000
+300.0%
9
+800.0%
0.00%
Q4 2017$1,000
-90.0%
1
-95.8%
0.00%
Q2 2017$10,000
-89.6%
24
-92.6%
0.00%
-100.0%
Q1 2017$96,000
-15.0%
323
+15.4%
0.00%
-42.9%
Q4 2016$113,000
+3666.7%
280
+5500.0%
0.01%
Q3 2016$3,000
-85.7%
5
-82.1%
0.00%
-100.0%
Q2 2016$21,000
+90.9%
28
+100.0%
0.00%0.0%
Q1 2016$11,000
+266.7%
14
-48.1%
0.00%
Q4 2015$3,000
-76.9%
27
+107.7%
0.00%
-100.0%
Q3 2015$13,00013
+8.3%
0.00%
Q2 2015$012
+500.0%
0.00%
Q1 2015$020.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q1 2023
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 16,200$649,6200.00%
JANE STREET GROUP, LLC 60,000$2,406,0000.00%
SIMPLEX TRADING, LLC 3,200$1280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders